E-LIB Suche - Ergebnisse für: El-Beshlawy, Amal

1

Management of transfusion-dependent β-thalassemia (TDT): Ex..:

El-Beshlawy, Amal ; Dewedar, Hany ; Hindawi, Salwa...
Blood Reviews. 63 (2024) - p. 101138 , 2024

Link: https://doi.org/10.1016/..

2

Predicting inhibitor development using a random peptide pha..:

Hassan, Shermarke ; Baselli, Guido ; Mollica, Luca...
Blood Advances. 8 (2024) 11 - p. 2880-2889 , 2024

Link: https://doi.org/10.1182/..

3

Plain language summary of a study looking at the long-term ..:

El-Beshlawy, Amal ; Tylki-Szymanska, Anna ; Belmatoug, Nadia.
Future Rare Diseases. 4 (2024) 1 - p. , 2024

Link: https://doi.org/10.2217/..

4

Egyptian Gaucher disease type 3 patients: a large cohort st..:

El-Beshlawy, Amal ; Abdel-Azim, Khaled ; Abdel-Salam, Amina...
Journal of Rare Diseases. 2 (2023) 1 - p. , 2023

Link: https://doi.org/10.1007/..

5

Deferiprone for transfusional iron overload in sickle cell ..:

Elalfy, Mohsen S. ; Hamdy, Mona ; El-Beshlawy, Amal...
Blood Advances. 7 (2023) 4 - p. 611-619 , 2023

Link: https://doi.org/10.1182/..

6

Development of a Thalassemia International Prognostic Scori..:

Vitrano, Angela ; Musallam, Khaled M. ; Meloni, Antonella...
Blood Cells, Molecules, and Diseases. 99 (2023) - p. 102710 , 2023

Link: https://doi.org/10.1016/..

7

Magnitude of cumulative iron overload correlates with the s..:

Musallam, Khaled M. ; Cappellini, Maria Domenica ; Daar, Shahina..
Annals of Hematology. 102 (2022) 2 - p. 467-469 , 2022

Link: https://doi.org/10.1007/..

8

Deferiprone vs deferoxamine for transfusional iron overload..:

Kwiatkowski, Janet L. ; Hamdy, Mona ; El-Beshlawy, Amal...
Blood Advances. 6 (2022) 4 - p. 1243-1254 , 2022

Link: https://doi.org/10.1182/..

9

Random Forest Clustering Identifies Three Subgroups of β-Th..:

Vitrano, Angela ; Musallam, Khaled M. ; Meloni, Antonella...
Thalassemia Reports. 12 (2022) 1 - p. 14-23 , 2022

Link: https://doi.org/10.3390/..

10

Survival and causes of death in 2,033 patients with non-tra..:

Musallam, Khaled M. ; Vitrano, Angela ; Meloni, Antonella...
Haematologica. 106 (2021) 9 - p. 2489-2492 , 2021

Link: https://doi.org/10.3324/..

11

A study of red blood cell alloimmunization and autoimmuniza..:

El-Beshlawy, Amal ; Salama, Alshymaa Ahmed ; El-Masry, Mohamed Roshdy..
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

12

Recent trends in treatment of thalassemia:

El-Beshlawy, Amal ; El-Ghamrawy, Mona
Blood Cells, Molecules, and Diseases. 76 (2019) - p. 53-58 , 2019

Link: https://doi.org/10.1016/..

13

Addendum to Letter to the Editor: Safety, efficacy, and aut..:

Mistry, Pramod K. ; Balwani, Manisha ; Baris, Hagit N....
Blood Cells, Molecules, and Diseases. 77 (2019) - p. 101-102 , 2019

Link: https://doi.org/10.1016/..

14

Guidelines for the management of haemophilia in Egypt:

Mokhtar, Galila ; El-Beshlawy, Amal ; El Alfy, Mohssen...
The Journal of Haemophilia Practice. 5 (2018) 1 - p. 83-92 , 2018

Link: https://doi.org/10.17225..

15

International sentinel site surveillance of patients with t..:

El-Beshlawy, Amal ; Inusa, Baba ; Beneitez Pastor, David...
Hematology. 24 (2018) 1 - p. 238-246 , 2018

Link: https://doi.org/10.1080/..